SK Biopharmaceuticals said Wednesday it is accelerating its expansion into Latin America by launching its epilepsy treatment Cenobamate in Brazil, as the firm's

SK Biopharmaceuticals CEO Lee Dong-hoon, third from left, poses with Eurofarma Global CEO Marco Billi, fourth from left, after signing a memorandum...

SK Biopharmaceuticals said Wednesday it is accelerating its expansion into Latin America by launching its epilepsy treatment Cenobamate in Brazil, as the firm's